Physician profile
Tien Dang
NPI 1972988798
$3,519.81
in general payments reported to CMS, 2019-2025
12 companies · $446 in 2025
The $446 reported for 2025 was more than what 89% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $285 · 2021: $40.77 · 2022: $100 · 2023: $1,076 · 2024: $71.79 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922 · Travel and Lodging: $384 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.21 |
| Travel and Lodging | $383.97 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Sirona INC | $1,069.01 | 2023-2025 | Cerec, Waveone Gold Conform Fit, Primescan Connect |
| Benco Dental Supply Co. | $383.97 | 2025 | |
| A-Dec, INC. | $285.00 | 2020 | |
| Henry Schein, INC. | $149.42 | 2022-2023 | |
| Philips North America LLC | $49.03 | 2021-2024 | (E55) Oral Health Care Und |
| 3m Company | $19.87 | 2022 | |
| Solventum Corporation | $15.74 | 2025 | 3m, 3m Relyx, 3m Clinpro |
| Straumann USA LLC | $14.43 | 2024 | |
| Kuraray America INC. | $13.84 | 2023 | |
| Carestream Dental, LLC | $13.31 | 2021 | |
| Voco America INC. | $6.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tien Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.